Displaying 1 to 17 of 17 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. |
United States | Seed Initial investment. Active |
|||
BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. |
United States | 4 Jun 2007 | Series A Follow-on investment. Round participant. Active |
||
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | 1 Apr 2008 | Series B Active |
||
Cambrios Technologies Corp Developer of proprietary nanostructured electronic materials for the display industry |
United States | 1 Nov 2009 | Series D Initial investment. Round participant. Active |
||
Cerulean Pharma Inc |
United States | 1 Jan 2008 | Series B |
||
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | N/A Active |
|||
Genocea Biosciences Inc |
United States | N/A |
|||
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | N/A Active |
|||
Magen BioSciences Inc |
United States | N/A |
|||
MAP Pharmaceuticals Inc Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. |
United States | N/A |
|||
Metabolon Inc Provider of biomarker discovery and analysis |
United States | 7 Dec 2009 | Series C |
||
MiddleBrook Pharmaceuticals Inc A pharmaceutical company engages in the development and commercialization of anti-infective drug products. |
United States | N/A |
|||
Nanosys Inc Nanotechnology-enabled systems |
United States | N/A Active |
|||
Sirtris Pharmaceuticals Inc |
United States | 19 Apr 2006 | Series C Active |
||
Theraclone Sciences Inc |
United States | 1 Mar 2010 | N/A |
||
Theraclone Sciences Inc |
United States | 1 Sep 2011 | Series B |
||
VLST Corp |
United States | N/A |